Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Sarcoma 7Neoplasms 2Leiomyosarcoma 2Wilms Tumor 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Neuroblastoma 1Neoplasms, Connective and Soft Tissue 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Lung Neoplasms 1Liver Diseases 1Liposarcoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hepatic Insufficiency 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

Irinotecan 6Cyclophosphamide 3temsirolimus 2Sirolimus 2Filgrastim 2Carboplatin 2sargramostim 1reolysin 1irofulven 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Topotecan 1Tirapazamine 1Thiotepa 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Oxaliplatin 1Methylprednisolone 1Melphalan 1Immunologic Techniques 1Immunohistochemistry 1Gemcitabine 1Gefitinib 1Flow Cytometry 1Etoposide 1Enzyme-Linked Immunosorbent Assay 1Cyclosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Unspecified Childhood Solid Tumor, Protocol Specific × Trabectedin × Clear all
NCT00006463 2014-02-21

Ecteinascidin 743 in Treating Children With Refractory Solid Tumors

Children's Oncology Group

Phase 1 Completed
13 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡